Home » Thought Leadership » Infographics » ICER Released First Cost-Effec…

ICER Released First Cost-Effectiveness Assessment for a Digital Therapeutic (DTx)

November 3, 2020


Written by: Tom Rutkowski Patrick Buck

Three digital health technologies have been developed to treat opioid use disorder (OUD). These applications, reSET-O (Pear Therapeutics), Connections (Chess Health), and DynamiCare (DynamiCare Health), aim to increase the adherence of OUD patients through virtual counseling, training programs, incentives, and support groups.

In this infographic, CBPartners assesses the impact of ICER’s first cost-effectiveness assessment for a digital therapeutic.

Read the infographic here.


If you are interested in reading more about the digital therapeutics landscape, read related posts in the expertise team’s thought leadership channel.